These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25015320)

  • 1. E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma.
    Wang J; Huang Y; Guan Z; Zhang JL; Su HK; Zhang W; Yue CF; Yan M; Guan S; Liu QQ
    Oncotarget; 2014 Jul; 5(14):5591-601. PubMed ID: 25015320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Skp2 overexpression to prognosis of patients with nasopharyngeal carcinoma from South China.
    Xu HM; Liang Y; Chen Q; Wu QN; Guo YM; Shen GP; Zhang RH; He ZW; Zeng YX; Xie FY; Kang TB
    Chin J Cancer; 2011 Mar; 30(3):204-12. PubMed ID: 21352698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPP2 promotes the proliferation of nasopharyngeal carcinoma through upregulating Skp2/c-Myc.
    Zhang T; Yu GD; Ye HP; Jin Y
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8001-8007. PubMed ID: 32767326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy.
    Liu B; Tan Z; Jiang Y; Chen Y; Chen Y; Ling K
    J BUON; 2018; 23(6):1671-1678. PubMed ID: 30610793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.
    Yu X; Wang R; Zhang Y; Zhou L; Wang W; Liu H; Li W
    Oncogene; 2019 Dec; 38(50):7457-7472. PubMed ID: 31435020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased
    Wu S; Peng L
    J Int Med Res; 2024 Sep; 52(9):3000605241271754. PubMed ID: 39286844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Coding RNA Pvt1 Promotes Cancer Stem Cell-Like Traits in Nasopharyngeal Cancer via Inhibiting miR-1207.
    Cui M; Chang Y; Fang QG; Du W; Wu JF; Wang JH; Liu ST; Luo SX
    Pathol Oncol Res; 2019 Oct; 25(4):1411-1422. PubMed ID: 30141114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties.
    Li JY; Xiao T; Yi HM; Yi H; Feng J; Zhu JF; Huang W; Lu SS; Zhou YH; Li XH; Xiao ZQ
    Cancer Lett; 2019 Mar; 444():162-174. PubMed ID: 30583071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical Expression and Clinical Significance of WWP1 Protein in Nasopharyngeal Cancer.
    Chen H; Li C; He S; Ling J; Zhao H; Zhuo X
    J Histochem Cytochem; 2024 Jun; 72(6):363-371. PubMed ID: 38804681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma.
    Lian YF; Yuan J; Cui Q; Feng QS; Xu M; Bei JX; Zeng YX; Feng L
    PLoS One; 2016; 11(3):e0152820. PubMed ID: 27030985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q; Hou S; Zhu X; Liu S
    World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 14. Down-regulation of Sp1 suppresses cell proliferation, clonogenicity and the expressions of stem cell markers in nasopharyngeal carcinoma.
    Zhang JP; Zhang H; Wang HB; Li YX; Liu GH; Xing S; Li MZ; Zeng MS
    J Transl Med; 2014 Aug; 12():222. PubMed ID: 25099028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential.
    Tian YF; Chen TJ; Lin CY; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Shiue YL; Huang HY; Pan HY; Li CF; Chen SH
    Tumour Biol; 2013 Apr; 34(2):1107-17. PubMed ID: 23328995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).
    Zhang SQ; Pan SM; Liang SX; Han YS; Chen HB; Li JC
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
    Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
    Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
    Deng YF; Zhou DN; Pan ZY; Yin P
    Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ABCG2⁺ cells in nasopharyngeal carcinoma cells.
    Zhang H; Liu W; Feng X; Wang L; Jiang X; Liu D; Zhang L; Zhu B; Zhou W; Jia W; Li G; Ren C
    Oncol Rep; 2012 Apr; 27(4):1177-87. PubMed ID: 22209971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
    Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
    Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.